Position in NTLA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,280,559
+$381,219 QoQ
Shares Held
333,897
-23.0% QoQ
Ownership
0.239%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Derivatives in NTLA
reported options exposure · as of Sep 30, 2022CallValue
$1,712,376
CallShares
30,600
PutValue
$1,152,776
PutShares
20,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. NTLA ranks #33 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in NTLA
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,280,559 | 333,897 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,899,340 | 433,742 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $9,322,602 | 539,815 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,236,453 | 238,428 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,542,235 | 357,558 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,237,888 | 277,692 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,126,849 | 200,820 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,513,083 | 201,657 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,935,501 | 215,758 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $6,177,089 | 202,594 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $7,176,757 | 226,969 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,642,292 | 187,403 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $6,089,915 | 163,400 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,445,299 | 70,086 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,701,980 | 84,024 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $1,152,776 | 20,600 | Put | Defined | 2022-11-14 | |
| 2022-09-30 | $1,712,376 | 30,600 | Call | Defined | 2022-11-14 | |
| 2022-06-30 | $3,871,646 | 74,800 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,204,647 | 99,142 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $15,272,232 | 129,163 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $17,233,310 | 128,463 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,549,056 | 114,564 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,105,306 | 125,915 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $8,418,997 | 154,761 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,323,769 | 66,588 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $2,320,080 | 110,375 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $987,290 | 80,727 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||